Simcorp Taps into Bloomberg's EMSxNET

Buy-side clients will now have access to over 5,000 brokers.

copenhaegen-landscape
Simcorp is headquarted in Copenhagen.

EMSxNET provides connectivity to over 5,000 brokers, including over 600 emerging markets destinations. Real-time transaction cost analysis (TCA) tools and data visualization allow users to monitor and manage execution. Order and broker performance monitoring is also available.

"With this partnership, our rising list of clients can leverage the broad reach of EMSxNET connectivity as well as a stronger integration with the Bloomberg terminal," said Brent Rossum, director of front-office product management at SimCorp. "This will especially be of value to the large and sophisticated investment managers in our client base and is yet another example that we continue to expand and refine the capabilities of our front-office solutions to help our clients operate efficiently."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Banks seemingly build more than buy, but why?

Waters Wrap: A new report states that banks are increasingly enticed by the idea of building systems in-house, versus being locked into a long-term vendor contract. Anthony explores the reason for this shift.

Pushing the boundaries of TCA

S&P Global Market Intelligence finished runner-up in the perennially competitive TCA system provider category of the Waters Rankings 2024. Michael Richter, global head of trading analytics, discusses the TCA challenges facing the firm’s buy- and sell…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here